Overview

Comparison of Three Methods for Early Detection of Breast Cancer

Status:
Enrolling by invitation
Trial end date:
2022-06-15
Target enrollment:
Participant gender:
Summary
Subjects with suspicious breast lesion (BIRADS category 4/5) who are scheduled to undergo biopsy will be recruited to undergo imaging evaluation with Contrast Enhanced Dual Energy Mammography (CEDM), Contrast Enhanced Breast MR (CEMR) and Contrast Enhanced Ultrasound (CEUS).
Phase:
Early Phase 1
Details
Lead Sponsor:
Mayo Clinic